Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin, or both. Diabetes is a disorder of metabolism, the process by which the body uses digested food for energy. There are two main forms of the diabetes. People with type 1 diabetes typically make none of their own insulin and therefore require insulin injections to survive. People with type 2 diabetes, the form that comprises some 90% of cases, usually produce their own insulin, but not enough or they are unable to use it properly. People with type 2 diabetes are typically overweight and sedentary, two conditions that raise a person’s insulin needs. It may also be seen during pregnancy.

The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Novo-Nordisk, Sanofi-Aventis, Eli Lilly and Takeda are being profiled.

The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing healthcare expenditure, accelerating economic growth, growing obese population, opportunities for growth in emerging markets and bariatric surgery for treating diabetes on the rise. Some of the noteworthy trends and developments of this industry are advances in medical devices, rising prevalence of diabetes and desk bound lifestyle and second hand smoke. However, the expansion of the market is hindered by increasing diabetes cost.